XML 42 R32.htm IDEA: XBRL DOCUMENT v3.20.4
Note 13 - Capital Stock (Tables)
6 Months Ended
Jan. 31, 2021
Notes Tables  
Schedule of Warrants, Valuation Assumptions [Table Text Block]
Expected Risk Free Interest Rate
   
0.14
%
Expected Annual Volatility
   
76.81
%
Expected Contractual Life in Years
   
2.00
 
Expected Annual Dividend Yield
   
0.00
%
Schedule of Net Proceeds Allocation [Table Text Block]
Fair Value of Shares
  $
12,000,000
 
Fair Value of Share Purchase Warrants
   
1,445,756
 
Total Fair Value Before Allocation to Net Proceeds
  $
13,445,756
 
         
Gross Proceeds
  $
15,000,000
 
Share Issuance Costs - Cash
   
(878,344
)
Net Cash Proceeds Received
  $
14,121,656
 
         
Relative Fair Value Allocation to:
 
 
 
 
Shares
  $
12,603,224
 
Share Purchase Warrants
   
1,518,432
 
    $
14,121,656
 
Schedule Of Share based Compensation Warrants Activity [Table Text Block]
   
Number of

Warrants
   
Weighted Average

Exercise Price
 
Balance, July 31, 2020
   
7,721,981
    $
2.03
 
Issued in connection with September 2020 Offering
   
6,833,333
     
1.80
 
Balance, October 31, 2020
   
14,555,314
     
1.92
 
Exercised
   
(1,050
)    
1.80
 
Expired
   
(300,000
)    
1.38
 
Balance, January 31, 2021
 
 
14,254,264
   
$
1.93
 
Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]
Weighted Average

Exercise Price
   
Number of Warrants

Outstanding
   
Weighted Average Remaining Contractual

Life (Years)
 
Expiry Date
$ 2.05      
7,063,253
     
0.17
 
April 3, 2021
  2.30      
308,728
     
1.52
 
August 9, 2022
  1.64      
50,000
     
2.30
 
May 21, 2023
  1.80      
6,832,283
     
1.64
 
September 23, 2022
$ 1.93      
14,254,264
     
0.91
 
 
Share-based Payment Arrangement, Option, Activity [Table Text Block]
   
Number of Stock Options
   
Weighted Average Exercise Price
 
Balance, July 31, 2020
   
15,514,750
    $
1.13
 
Exercised
   
(28,500
)    
0.93
 
Expired
   
(1,315,000
)    
1.43
 
Balance, October 31, 2020
   
14,171,250
     
1.10
 
Exercised
   
(1,100,782
)    
1.11
 
Balance, January 31, 2021
   
13,070,468
    $
1.10
 
Cash Proceeds Received and Tax Benefit from Share-based Payment Awards [Table Text Block]
   
Three Months Ended January 31,
   
Six Months Ended January 31,
 
   
2021
   
2020
   
2021
   
2020
 
Number of Options Exercised on Forfeiture Basis
 
 
923,282
   
 
-
   
 
941,782
   
 
-
 
Number of Options Exercised on Cash Basis
 
 
177,500
   
 
-
   
 
187,500
   
 
-
 
Total Number of Options Exercised
 
 
1,100,782
   
 
-
   
 
1,129,282
   
 
-
 
                                 
Number of Shares Issued on Cash Exercise
 
 
177,500
   
 
-
   
 
187,500
   
 
-
 
Number of Shares Issued on Forfeiture Basis
 
 
382,028
   
 
-
   
 
385,560
   
 
-
 
Total Number of Shares Issued Upon Exercise of Options
 
 
559,528
   
 
-
   
 
573,060
   
 
-
 
                                 
Cash Received from Exercise of Stock Options
 
$
212,125
    $
-
   
$
221,434
    $
-
 
Total Intrinsic Value of Options Exercised
 
$
822,237
    $
-
   
$
828,615
    $
-
 
Disclosure of Share-based Compensation Arrangements by Share-based Payment Award [Table Text Block]
   
Number of Unvested
Stock Options
   
Weighted Average
Grant-Date Fair Value
 
Balance, July 31, 2020
   
6,797,471
    $
0.46
 
Vested
   
(718,755
)    
0.46
 
Balance, October 31, 2020
   
6,078,716
     
0.46
 
Vested
   
(1,042,559
)    
0.48
 
Balance, January 31, 2021
   
5,036,157
    $
0.45
 
Share-based Payment Arrangement, Option, Exercise Price Range [Table Text Block]
 
     
Options Outstanding
   
Options Exercisable
 
Range of Exercise Prices
 
Outstanding at
Janury 31, 2021
   
Weighted Average Exercise Price
   
Weighted Average Remaining Contractual Term (Years)
   
Exercisable at

January 31, 2021
   
Weighted Average Exercise Price
   
Weighted Average Remaining Contractual Term (Years)
 
$0.80
to
$0.99
   
7,481,468
    $
0.92
     
7.55
     
3,816,561
    $
0.92
     
5.98
 
$1.00
to
$1.49
   
3,587,000
     
1.18
     
4.57
     
2,215,750
     
1.24
     
1.65
 
$1.50
to
$2.81
   
2,002,000
     
1.65
     
2.29
     
2,002,000
     
1.65
     
2.29
 
 
 
 
   
13,070,468
    $
1.10
     
5.93
     
8,034,311
    $
1.19
     
3.87
 
Schedule of Nonvested Restricted Stock Units Activity [Table Text Block]
Grant Date
 
Number of Restricted Stock Units
   
Grant Date Fair Value
   
Remaining Life (Years)
   
Aggregate Intrinsic Value
 
July 30, 2019
   
310,000
    $
0.94
     
1.49
    $
505,300
 
July 16, 2020
   
1,305,000
     
0.91
     
2.45
     
2,127,150
 
     
1,615,000
    $
0.92
     
2.27
    $
2,632,450
 
Share-based Payment Arrangement, Cost by Plan [Table Text Block]
   
Three Months Ended January 31,
   
Six Months Ended January 31,
 
   
2021
   
2020
   
2021
   
2020
 
Stock-Based Compensation for Consultants
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Common stock issued to consultants
 
$
119,847
    $
126,150
   
$
239,317
    $
233,758
 
Amortization of stock option expenses
 
 
65,774
     
53,554
   
 
169,702
     
100,525
 
   
 
185,621
     
179,704
   
 
409,019
     
334,283
 
Stock-Based Compensation for Management
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Common stock issued to management
 
 
-
     
34,100
   
 
-
     
68,807
 
Amortization of stock option expenses
 
 
206,317
     
162,728
   
 
460,048
     
406,105
 
Amortization of RSU & PRSU expenses
 
 
309,378
     
135,093
   
 
618,756
     
270,186
 
   
 
515,695
     
331,921
   
 
1,078,804
     
745,098
 
Stock-Based Compensation for Employees
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Common stock issued to employees
 
 
261,642
     
129,997
   
 
474,512
     
258,025
 
Amortization of stock option expenses
 
 
255,100
     
156,628
   
 
634,238
     
393,419
 
   
 
516,742
     
286,625
   
 
1,108,750
     
651,444
 
                                 
Settlement of share issuance obligation
 
 
-
     
-
   
 
-
     
(15,189
)
   
$
1,218,058
    $
798,250
   
$
2,596,573
    $
1,715,636